Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

American Pharmaceutical Review

In fact, we have talked about the Durbin-Watson statistics in previous chapters, although a long time ago and under a different name. Quite a while ago we published a column titled Alternative Ways to Calculate Standard Deviation [7], One of the alternative ways described was the calculation by Successive Differences. As we shall see, that calculation is very closely related indeed to the Durbin-Watson Statistic. More recently we described this statistic (more directly named) in a sidebar to an article in the American Pharmaceutical Review [8],... [Pg.427]

Trappier, E. Scale-up Strategy for a lyophilized process. American Pharmaceutical Review Fall 2001. [Pg.363]

Warman, M., Using Near Infrared Spectroscopy to Unlock the Pharmaceutical Blending Process American Pharmaceutical Review 2004, 7(2), 54-57. [Pg.224]

Gray, V.A. Dissolution testing using fiber optics—a regulatory perspective. American Pharmaceutical Review 2003, 6 (2), 26-30. [Pg.928]

Fig. 3 TIC from the GC/MS analysis of an elastomer methylene chloride extract. (From Ref., reproduced with permission from American Pharmaceutical Review.)... Fig. 3 TIC from the GC/MS analysis of an elastomer methylene chloride extract. (From Ref., reproduced with permission from American Pharmaceutical Review.)...
Lohr, L. L., Sharp, T. R., Alsante, K. M. and Hatajik, T. D. Isolation and identification of process related impurities and degradation products from pharmaceutical drug candidates Part II—the roles of NMR and mass spectrometry. American Pharmaceutical Review 4 70-78, 2001. [Pg.358]

Thomas Layloff An overview of process analytical technology in the pharmaceutical industry. American Pharmaceutical Review, 1 (3), May-June, 30-34, 2004. [Pg.380]

Figure 21.1 Nanomaterial properties vary depending on a number of important characteristics, such as shape, concentration (dose/response), surface composition, and aggregation for passive and active (changing) nanostmctures. (Modified and adapted from A. P. Tinke et al., American Pharmaceutical Review, 2006, 9(6), September/October, 1.)... Figure 21.1 Nanomaterial properties vary depending on a number of important characteristics, such as shape, concentration (dose/response), surface composition, and aggregation for passive and active (changing) nanostmctures. (Modified and adapted from A. P. Tinke et al., American Pharmaceutical Review, 2006, 9(6), September/October, 1.)...
A. R Tinke, R. Govoreanu, K. Vanhoutte, American Pharmaceutical Review 2006, 9(6), September/October, 1. [Pg.714]

Along with an increase in PAT-related presentations there has been a dramatic increase in the number of publications documenting the technical developments and their impact A journal of PAT has been established (www.patjournal.com) and a number of trade journal articles have also been published on the importance of microinstrumentation developments for PAT. These trade journals include Control Magazine, Chemical Processing, Chemical and Engineering News, American Pharmaceutical Review and European Pharmaceutical Review. There are also periodic reviews of the PAT field in the journal Analytical Chemistry (4, 5]. [Pg.1106]

T Randolph, J Searles. Freezing and annealing phenomena in lyophilization effects upon primary drying rate, morphology, and heterogeneity. American Pharmaceutical Review 5 40-46, 2002. [Pg.165]

A significant survey response indicated the importance of both design and service features to advance roller compaction technology (33). There seems to be an assorted blend of needs that are due in part to vendor past performances, such as reliability, technical support programs, and service history. There is also a component of innovation, new technology advances, such as cantilevered rolls and operator touch screens with parametric feedback [Table 3, courtesy of the American Pharmaceutical Review (33)]. [Pg.173]

C. Moreton, Functionality and performance of excipients in a quality-by-design world part 2 Excipient variability, QbD and robust formulations, American Pharmaceutical Review, 12,40-45, 2009. [Pg.27]

Ritchie, G. E. andHashemi, American Pharmaceutical Review, GMP Roll Out and Implementation of Near Infrared Spectrophotometry for Pharmaceutical Testing, Spring (2003). [Pg.263]

Schadt, R., Process Analytical Technology — Changing the Validation Paradigm, American Pharmaceutical Review, 2004, 7 58-61. [Pg.263]

Tu, R.S., K. Mohanty, and M.V. Tirrell. 2004. Liposomal targeting through peptide-amphiphile functionalization. American Pharmaceutical Review 7(2) 36-41. [Pg.146]


See other pages where American Pharmaceutical Review is mentioned: [Pg.434]    [Pg.234]    [Pg.267]    [Pg.267]    [Pg.331]    [Pg.968]    [Pg.434]    [Pg.160]    [Pg.161]    [Pg.394]   
See also in sourсe #XX -- [ Pg.423 ]

See also in sourсe #XX -- [ Pg.427 ]




SEARCH



© 2024 chempedia.info